117 related articles for article (PubMed ID: 33878875)
1. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.
Cardoso CRL; Villela-Nogueira CA; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Sep; 20(1):193. PubMed ID: 34560854
[TBL] [Abstract][Full Text] [Related]
3. Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease.
Zhang W; Song WJ; Chen W; Pan Z; Zhang J; Fan L; Li J
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):802-810. PubMed ID: 38526946
[TBL] [Abstract][Full Text] [Related]
4. Transient elastography and controlled attenuation parameter to evaluate hepatic steatosis and liver stiffness in postpartum patients.
Hussain FN; Rosenbluth E; Feldman KM; Strauss TS; Schneider E; Schmidt-Beauchat E; Rodriguez-Rivas C; Brustman L; Kushner T
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2190838. PubMed ID: 36935368
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of hepatic steatosis and steatohepatitis in people with new-onset type 2 diabetes: a multidisciplinary approach.
Barana L; Nelva A; Scivetti P; Costanzo M; Fanelli CG
Endocrine; 2024 May; 84(2):412-419. PubMed ID: 38347338
[TBL] [Abstract][Full Text] [Related]
6. Role of Alanine Transaminase and Transient Elastography in Categorising Nonalcoholic Fatty Liver Disease Subgroups.
Shabbir A; Abbas Z; Khatoon A; Mirza T
J Coll Physicians Surg Pak; 2024 Jan; 34(1):22-26. PubMed ID: 38185955
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus.
Judi L; Toukan A; Khader Y; Ajlouni K; Khatib MA
Ann Saudi Med; 2010; 30(1):25-32. PubMed ID: 20103955
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data.
Andersen G; Plum-Mörschel L; Hockings PD; Morsing A; Palle MS; Svolgaard O; Flint A
Adv Ther; 2020 Dec; 37(12):4866-4876. PubMed ID: 33006125
[TBL] [Abstract][Full Text] [Related]
9. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure.
Misan IA; Arisheva OS; Garmash IV; Cabello FR; Kobalava ZD
Kardiologiia; 2023 Dec; 63(12):72-76. PubMed ID: 38156493
[TBL] [Abstract][Full Text] [Related]
11. Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study.
Corbin KD; Pittas AG; Desouza C; Grdinovac KK; Herzig KH; Kashyap SR; Kim SH; Nelson J; Rasouli N; Vickery EM; Knowler WC; Pratley RE
J Diabetes Complications; 2023 Jun; 37(6):108475. PubMed ID: 37104979
[TBL] [Abstract][Full Text] [Related]
12. Vibration Controlled Transient Elastography in Screening for Silent Liver Diseases.
Said E; Abdel-Gawad M; Abdelsameea E; Elshemy EE; Abdeen N; Elbasiony M; Omran D; Elesnawy Y; Eid A; Lashen SA; Elbahr O; Naguib GG; Afify S; Bahbah EI; Alboraie M
Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1204-1210. PubMed ID: 37577784
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
Man S; Deng Y; Ma Y; Fu J; Bao H; Yu C; Lv J; Liu H; Wang B; Li L
Gastroenterology; 2023 Oct; 165(4):1025-1040. PubMed ID: 37380136
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
Zhou K; Dodge JL; Yuan L; Terrault NA
Dig Dis Sci; 2022 Jul; 67(7):3340-3355. PubMed ID: 34173916
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies.
Forlano R; Stanic T; Jayawardana S; Mullish BH; Yee M; Mossialos E; Goldin R; Petta S; Tsochatzis E; Thursz M; Manousou P
Liver Int; 2024 Jan; 44(1):61-71. PubMed ID: 37718933
[TBL] [Abstract][Full Text] [Related]
16. Association of the Non-Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross-sectional study in China.
Fan N; Ding X; Zhen Q; Gu L; Zhang A; Shen T; Wang Y; Peng Y
J Diabetes Investig; 2021 Jun; 12(6):1035-1041. PubMed ID: 33030804
[TBL] [Abstract][Full Text] [Related]
17. Sex Differences in the Association Between AST/ALT and Incidence of Type 2 Diabetes in Japanese Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Cohort Study.
Zhang C; Xu Q; Xu C; Yang K; Xia T; Hasi W; Hao M; Kuang H
Endocr Res; 2024 Jan; 49(1):1-11. PubMed ID: 37752709
[TBL] [Abstract][Full Text] [Related]
18. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Sangouni AA; Nadjarzadeh A; Rohani FS; Sharuni F; Zare Z; Rahimpour S; Hojjat H; Hosseinzadeh M
Eur J Nutr; 2024 Feb; 63(1):95-105. PubMed ID: 37855891
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study.
Lee HH; Cho Y; Choi YJ; Huh BW; Lee BW; Kang ES; Park SW; Cha BS; Lee EJ; Lee YH; Huh KB
Cardiovasc Diabetol; 2020 Jun; 19(1):81. PubMed ID: 32534588
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
Huang DQ; Wilson LA; Behling C; Kleiner DE; Kowdley KV; Dasarathy S; Amangurbanova M; Terrault NA; Diehl AM; Chalasani N; Neuschwander-Tetri BA; Sanyal AJ; Tonascia J; ; Loomba R
Gastroenterology; 2023 Aug; 165(2):463-472.e5. PubMed ID: 37127100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
